CIA
GOSS icon

Caerus Investment Advisors’s Gossamer Bio GOSS Stock Holding History

Caerus Investment Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27K Buy
172
+24
+16% +$536 ﹤0.01% 339
2026
Q1 		$3.89K Buy
+148
New +$18.6K ﹤0.01% 281

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Caerus Investment Advisors's GOSS Position: Q2 2026 in Review

Caerus Investment Advisors increased its Gossamer Bio (GOSS) stake by 16% in Q2 2026, buying an estimated $536 and bringing the position to 172 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

Caerus Investment Advisors first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.89K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Caerus Investment Advisors held 172 shares of Gossamer Bio worth $2.27K as of Q2 2026.
  • Caerus Investment Advisors bought 24 Gossamer Bio shares in Q2 2026, an estimated $536.
  • Gossamer Bio made up ﹤0.01% of Caerus Investment Advisors's portfolio in Q2 2026, its #339 holding.
  • Caerus Investment Advisors first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Caerus Investment Advisors's Gossamer Bio position peaked at $3.89K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caerus Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.